The KYMAB brand, founded in 2010 (United Kingdom), from 2757 sister brands and 17477 competing brands. The KYMAB brand is owned by Sanofi, a company listed in Paris. The ISIN, the company's International Securities Identification Number, is FR0000120578. KYMAB belongs to the Drug Manufacturers business sector.

KYMAB is a brand of Sanofi (SAN) Share price

Share price and profitability of the share Sanofi (KYMAB)

Buy Sanofi share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 91.76

Portfolio valuation
Sanofi (KYMAB) over 5 years* EUR 107.32

Stock market history Sanofi (KYMAB)